Summary of Significant Accounting Policies (Tables)
|
3 Months Ended |
Mar. 31, 2026 |
|---|
| Accounting Policies [Abstract] |
|
| Schedule of Accounts Receivable |
Accounts
receivable consisted of the following as of the date indicated:
Schedule
of Accounts Receivable
| | |
March 31, 2026 | | |
December 31, 2025 | |
| | |
| | |
| |
| Accounts receivable | |
$ | 2,457,617 | | |
| 2,445,503 | |
| Less: Allowance for credit losses | |
| (379 | ) | |
| (258 | ) |
| Total accounts receivable, net | |
$ | 2,457,238 | | |
| 2,445,245 | |
|
| Schedule of Expected Credit Losses (Reversal) Provision |
Expected
credit losses (reversal) provision consisted for the following as of the dated indicated:
Schedule of Expected Credit Losses
(Reversal) Provision
| | |
March 31, 2025 | | |
December 31, 2025 | |
| | |
| | |
| |
| Balance – January 1 | |
$ | 258 | | |
| 367 | |
| Expected (reversal) of credit losses | |
| 121 | | |
| (109 | ) |
| Balance – December 31 | |
$ | 379 | | |
| 258 | |
|
| Schedule of Plant, Property and Equipment Estimated Lives Under Straight-Line Method |
Schedule
of Plant, Property and Equipment Estimated Lives Under Straight-Line Method
| Category | |
Estimated useful lives | |
| Computer and office equipment | |
| 5 - 10 years | |
| Decoration and renovation | |
| 5 - 10 years | |
|
| Schedule of Unrecognized Tax Benefits |
A
reconciliation of unrecognized tax benefits excluding interest and penalties (“Gross UTB”) for the three months ended March
31, 2026 and 2025, is as follows:
Schedule
of Unrecognized Tax Benefits
| | |
2026 | | |
2025 | |
| | |
Gross UTB | |
| | |
2026 | | |
2025 | |
| Balance – January 1 | |
| - | | |
| - | |
| Foreign exchange adjustment | |
| - | | |
| - | |
| Balance – March 31 | |
$ | - | | |
$ | - | |
|
| Schedule of Reconciliations of Basic and Diluted Loss Per Share |
The
following table presents a reconciliation of basic and diluted loss per share for the three months ended March 31, 2026 and 2025:
Schedule
of Reconciliations of Basic and Diluted Loss Per Share
| | |
2026 | | |
2025 | |
| | |
| | |
| |
| Net income (loss) | |
$ | 191,514 | | |
$ | (338,871 | ) |
| | |
| | | |
| | |
| Weighted average shares outstanding – Basic and Diluted * | |
| 44,829,706 | | |
| 9,780,576 | |
| | |
| | | |
| | |
| Net loss per share of common stock | |
| | | |
| | |
| Basic and Diluted | |
$ | 0.00 | | |
$ | (0.03 | ) |
| * |
Including
10,458,000 and 501,550 shares that were granted and vested but not yet issued for the three months ended March 31, 2026 and 2025, respectively. |
|
| Schedule of Concentration Credit Risk |
The
following table sets forth information as to the Company’s customers that accounted for 10% or more of the Company’s sales
and accounts receivable for the three months ended March 31, 2026 and 2025.
Schedule
of Concentration Credit Risk
Three Months Ended March 31, 2026 | |
As of March 31, 2026 | |
| Customer | |
Percentage of Total Sales | | |
Percentage of accounts receivable | |
| A | |
| 2 | % | |
| 1 | % |
Three Months Ended March 31, 2025 | |
As of March 31, 2025 | |
| Customer | |
Percentage of Total Sales | | |
Percentage of accounts receivable | |
| A | |
| 2 | % | |
| 14 | % |
The
following table sets forth information as to the Company’s suppliers that accounted for 10% or more of the Company’s total
purchases, accounts payable and advance to suppliers for the three months ended March 31, 2026 and 2025.
Three Months Ended March 31, 2026 | |
As of March 31, 2026 | | |
As of March 31, 2026 | |
| Supplier | |
Percentage of Total Purchases | | |
Balance of Accounts Payable | | |
Balance of Advance to Supplier | |
| A | |
| 16 | % | |
$ | 48,010 | | |
| - | |
| B | |
| 5 | % | |
| 13,077 | | |
| - | |
| C | |
| 2 | % | |
| - | | |
| - | |
| D | |
| 5 | % | |
| 28,300 | | |
| - | |
Three Months Ended March 31, 2025 | |
As of March 31, 2025 | | |
As of March 31, 2025 | |
| Supplier | |
Percentage of Total Purchases | | |
Balance of Accounts Payable | | |
Balance of Advance to Supplier | |
| A | |
| 11 | % | |
$ | 100,428 | | |
| - | |
| B | |
| 1 | % | |
| - | | |
| - | |
| C | |
| 3 | % | |
| 44,882 | | |
| - | |
| D | |
| 5 | % | |
| 13,740 | | |
| - | |
|
| Schedule of Exchange Rates |
Translation
of amounts from RM into U.S. dollars has been made at the following exchange rates:
Schedule
of Exchange Rates
| Balance sheet items, except for equity accounts | |
| | |
| March 31, 2026 | |
| - | |
| December 31, 2025 | |
| RM 4.06 to 1 | |
| | |
| | |
| Income Statement and cash flow items | |
| | |
| For the three months ended March 31, 2026 | |
| - | |
| For the three months ended March 31, 2025 | |
| RM 4.45 to 1 | |
|